FGFR1 FISH« Back to test list
Gene fusions involving the FGFR1 gene and other gene partners can occur in myeloid and lymphoid neoplasms, typically with eosinophilia. Such fusions have prognostic implications.
Presence of an FGFR1 gene fusion is typically associated with poor prognosis.
This is an assay for non-heritable mutations. It does not raise issues of ethics or consent that are different from most other investigations ordered in the routine care of a patient.
Fluorescent in situ hybridisation (FISH) analysis, using probes to identify fusion of FGFR1 with a partner gene.
This test is usually requested by a haematologist or oncologist.
0.5 mL bone marrow in transport media (or 10 mL blood in lithium heparin if blasts>10%).
To help ensure the quality of the test, a genetic test should be done with a dedicated sample whenever possible i.e. a sample collected specifically for that test rather than a sample that is used for multiple tests.
We also recommend that the patient or another adult check the labelling of request forms and sample tubes.